Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2026 ,inter alia, to consider and approve unaudited standalone and consolidated quarterly results 31.12.2025 on 25.02.2026
Board Meeting Intimation for Rescheduled Of Board Meeting On 25.02.2026
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Supha Pharmachem Ltd on 6ix
Story so far
- Board Meeting Intimation for Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December, 31, 2025
- Board Meeting Intimation for To Consider And Approve Unaudited Standalone And Consolidated Results For Quarter And Half Year Ended 30.09.2025
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, Meeting Of The Board Of Directors Scheduled On 22/09/2025
Earlier from Supha Pharmachem
- Supha Pharmachem Ltd Press Release Feb 03 2026
- Board Meeting Intimation for Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December, 31, 2025
- Supha Pharmachem Ltd Press Release Jan 20 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Supha Pharmachem Ltd Press Release Dec 22 2025
Later from Supha Pharmachem
- Intimation Of Change In Registered Office
- Supha Pharmachem Ltd Press Release Mar 17 2026
- Intimation Of Receipt Of Order From National Company Law Tribunal (NCLT)
- Supha Pharmachem Ltd Press Release Mar 21 2026
- Closure of Trading Window
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem